2014•Medical Innovation of ChinaRequires access

Clinical Efficacy Analysis of Nifedipine Combined with Magnesium Sulfate on Pregnancy-Induced Hypertension

Xiao Qion

Open publisher page 0 citations

Abstract

Objective: To investigate clinical efficacy of Nifedipine combined with magnesium sulfate on pregnancy-induced hypertension. Method: 80 cases of patients with pregnancy-induced hypertension in our hospital from March 2012 to March 2014 were selected and randomly divided into control group and observation group, 40 cases in each group. Patients in control group were given magnesium sulfate treatment, and patients in observation group were given nitrate benzene horizon combined magnesium sulfate. The blood pressure, birth outcomes, and adverse reactions of two groups were analyzed and compared. Result: Compared with before treatment, systolic and diastolic blood pressure of two groups were significantly reduced, and the reduce of observation group were more significantly(P0.05).The natural childbirth rate of observation group was 65.0%(26/40), which was significantly higher than 37.5%(15/40) of control group(P0.05). There was no serious adverse reactions in two groups. Conclusion: Nifedipine combined magnesium sulfate can effectively treat pregnancy-induced hypertension, with advantages of significantly blood pressure change and high natural childbirth compared with magnesium sulfate, worthy of promotion and application.

About this research paper

What this paper is about

Objective: To investigate clinical efficacy of Nifedipine combined with magnesium sulfate on pregnancy-induced hypertension. Method: 80 cases of patients with pregnancy-induced hypertension in our hospital from March 2012 to March 2014 were selected and randomly divided into control group and observation group, 40 cases in each group. Patients in control group were given magnesium sulfate treatment, and patients in observation group were given nitrate benzene horizon combined magnesium sulfate. The blood pressure, birth outcomes, and adverse reactions of two groups were analyzed and compared. Result: Compared with before treatment, systolic and diastolic blood pressure of two groups were significantly reduced, and the reduce of observation group were more significantly(P0.05).The natural childbirth rate of observation group was 65.0%(26/40), which was significantly higher than 37.5%(15/40) of control group(P0.05). There was no serious adverse reactions in two groups. Conclusion: Nifedipine combined magnesium sulfate can effectively treat pregnancy-induced hypertension, with advantages of significantly blood pressure change and high natural childbirth compared with magnesium sulfate, worthy of promotion and application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate clinical efficacy of Nifedipine combined with magnesium sulfate on pregnancy-induced hypertension. Method: 80 cases of patients with pregnancy-induced hypertension in our hospital from March 2012 to March 2014 were selected and randomly divided into control group and observation group, 40 cases in each group. Patients in control group were given magnesium sulfate treatment, and patients in observation group were given nitrate benzene horizon combined magnesium sulfate. The blood pressure, birth outcomes, and adverse reactions of two groups were analyzed and compared. Result: Compared with before treatment, systolic and diastolic blood pressure of two groups were significantly reduced, and the reduce of observation group were more significantly(P0.05).The natural childbirth rate of observation group was 65.0%(26/40), which was significantly higher than 37.5%(15/40) of control group(P0.05). There was no serious adverse reactions in two groups. Conclusion: Nifedipine combined magnesium sulfate can effectively treat pregnancy-induced hypertension, with advantages of significantly blood pressure change and high natural childbirth compared with magnesium sulfate, worthy of promotion and application.

Key concepts: Medicine, Blood pressure, Magnesium, Nifedipine, Adverse effect, Pregnancy, Anesthesia, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy Analysis of Nifedipine Combined with Magnesium Sulfate on Pregnancy-Induced Hypertension — Research Paper | ScholarLens